ATE209032T1 - Retinoid-formulierungen in porösen mikrokugeln für verringerte irritation und verbesserte stabilität - Google Patents

Retinoid-formulierungen in porösen mikrokugeln für verringerte irritation und verbesserte stabilität

Info

Publication number
ATE209032T1
ATE209032T1 AT96111446T AT96111446T ATE209032T1 AT E209032 T1 ATE209032 T1 AT E209032T1 AT 96111446 T AT96111446 T AT 96111446T AT 96111446 T AT96111446 T AT 96111446T AT E209032 T1 ATE209032 T1 AT E209032T1
Authority
AT
Austria
Prior art keywords
porous microspheres
improved stability
reduced irritation
retinoid formulations
retinoid
Prior art date
Application number
AT96111446T
Other languages
English (en)
Inventor
Michael Froix
Sergio Nacht
Masha Pukshansky
Original Assignee
Enhanced Derm Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enhanced Derm Technologies Inc filed Critical Enhanced Derm Technologies Inc
Application granted granted Critical
Publication of ATE209032T1 publication Critical patent/ATE209032T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0279Porous; Hollow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96111446T 1995-12-29 1996-07-16 Retinoid-formulierungen in porösen mikrokugeln für verringerte irritation und verbesserte stabilität ATE209032T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/581,126 US5851538A (en) 1995-12-29 1995-12-29 Retinoid formulations in porous microspheres for reduced irritation and enhanced stability

Publications (1)

Publication Number Publication Date
ATE209032T1 true ATE209032T1 (de) 2001-12-15

Family

ID=24323987

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96111446T ATE209032T1 (de) 1995-12-29 1996-07-16 Retinoid-formulierungen in porösen mikrokugeln für verringerte irritation und verbesserte stabilität

Country Status (11)

Country Link
US (1) US5851538A (de)
EP (1) EP0781551B1 (de)
JP (1) JP2960022B2 (de)
KR (1) KR100262117B1 (de)
AT (1) ATE209032T1 (de)
AU (1) AU697584B2 (de)
CA (1) CA2184433C (de)
DE (1) DE69617181T2 (de)
DK (1) DK0781551T3 (de)
ES (1) ES2168414T3 (de)
PT (1) PT781551E (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774907B1 (fr) * 1998-02-19 2000-05-12 Luc Dewandre Nouvelle formulation topique a base de retinaldehyde
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6683069B1 (en) 1998-04-02 2004-01-27 Regents Of The University Of Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6228894B1 (en) 1998-04-17 2001-05-08 Enhanced Derm Technologies, Inc. Softgel-compatible composition containing retinol
US5891470A (en) * 1998-04-17 1999-04-06 Advanced Polymer Systems, Inc. Softgel formulation containing retinol
BR9803936A (pt) 1998-09-08 2000-04-04 Cosmeticos Natural Ind Com Processo e composição para aumentar a ação de vitamina a na atividade celular de um indivìduo e uso de vitamina c.
US6194006B1 (en) * 1998-12-30 2001-02-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of microparticles having a selected release profile
AU2001252513A1 (en) 2000-04-21 2001-11-07 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
US7758888B2 (en) * 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
WO2001085102A2 (en) * 2000-05-05 2001-11-15 R.P. Scherer Technologies, Inc. Oil-in-water emulsion formulation containing hydroquinone and retinol
US6896890B2 (en) * 2000-05-05 2005-05-24 R.P. Scherer Technologies, Inc. Oil-in-water emulsion formulation containing free and entrapped hydroquinone and retinol
US6896905B2 (en) * 2001-02-15 2005-05-24 Rohm And Haas Company Porous particles, their aqueous dispersions, and method of preparation
US6590059B2 (en) 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
EP1304161B1 (de) * 2001-10-19 2007-02-28 Pacific Corporation Thermotropische, flüssigkristalline, polymerische Mikrokapseln, ihr Herstellungsverfahren sowie kosmetische Zubereitungen
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
AU2003301672A1 (en) * 2002-10-21 2004-05-13 Allegiance Corporation Coating composition for skin-contacting surface of elastomeric articles and articles containing the same
CN100462070C (zh) * 2003-06-30 2009-02-18 于美丽 一种维甲酸控释纳米微球及其制备方法
US20050002996A1 (en) * 2003-07-02 2005-01-06 Milan Sojka Sustained release compositions and controlled delivery method
JP2007518669A (ja) * 2003-12-15 2007-07-12 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ pH感受性ポリマーを含む風味マスクされる医薬組成物
JP2007518670A (ja) * 2003-12-15 2007-07-12 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ 苦味のある薬物、及びpH感受性ポリマーを含む風味マスクされた医薬組成物
CN100548270C (zh) * 2004-12-10 2009-10-14 科学与工业研究委员会 改善药物适口性的药用组合物及其制备方法
ES2900801T3 (es) * 2004-12-22 2022-03-18 Nitto Denko Corp Portador de fármacos y kit de portador de fármacos para inhibir la fibrosis
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
JP2009221164A (ja) 2008-03-17 2009-10-01 Nitto Denko Corp 肺線維症処置剤
US9868103B2 (en) * 2005-08-02 2018-01-16 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
JP5342834B2 (ja) * 2008-09-05 2013-11-13 日東電工株式会社 骨髄線維症処置剤
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
US20080020023A1 (en) 2006-07-20 2008-01-24 Shiping Wang Nonaqueous coating composition for elastomeric articles and articles containing the same
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
EP2109445B1 (de) * 2007-02-01 2022-04-20 Sol-Gel Technologies Ltd. Zusammensetzungen zur topischen anwendung mit einem peroxid und einem retinoid
FR2921257B1 (fr) * 2007-09-21 2009-11-06 Exsymol Sa Utilisation topique de derives thiazolidines contre les consequences du stress oxydatif de la peau
US8632816B2 (en) 2007-12-17 2014-01-21 Elc Management, Llc Compositions comprising solid particles entrapped in collapsed polymeric microspheres, and methods of making the same
US20090155371A1 (en) * 2007-12-17 2009-06-18 Sojka Milan F Compositions Comprising Solid Particles Entrapped In Collapsed Polymeric Microspheres, And Methods Of Making The Same
EP2247279A1 (de) * 2008-02-01 2010-11-10 Amcol International Corporation Verbesserte hautaufhellungszusammensetzungen
US20100040696A1 (en) * 2008-08-12 2010-02-18 Ilse Sente Composite Particles Having An Antioxidant-Based Protective System, And Topical Compositions Comprising The Same
WO2010030636A1 (en) * 2008-09-12 2010-03-18 Amcol International Corporation Low ph retinoid topical compositions
EP2391332A4 (de) * 2009-01-29 2015-06-17 Amcol International Corp Mattierungszusammensetzungen für die haut
KR101080186B1 (ko) * 2010-06-21 2011-11-07 주식회사 필라이트솔루션 개량형 led 조명등
JP5950428B2 (ja) 2010-08-05 2016-07-13 日東電工株式会社 線維化組織から正常組織を再生するための組成物
EP2862600B1 (de) 2011-12-20 2020-02-12 Oriflame Research and Development Ltd. Verbindungen mit Anti-Aging-Wirkung
EP2817069A1 (de) 2012-02-21 2014-12-31 Ranbaxy Laboratories Limited Zusammensetzung mit einem retinoid und benzoylperoxid
FR2991177B1 (fr) 2012-06-01 2014-12-19 Galderma Res & Dev Compositions topiques, contenant un retinoide, de type emulsion huile dans eau sans emulsionnant
FR2991180B1 (fr) * 2012-06-01 2014-06-13 Galderma Res & Dev Compositions topiques de type emulsion sans emulsionnant a base de particules stabilisantes.
US9084778B2 (en) 2012-06-01 2015-07-21 Galderma Research & Development Topical compositions containing a retinoid of the oil-in-water emulsion type
FR2991176B1 (fr) 2012-06-01 2014-12-19 Galderma Res & Dev Compositions topiques, contenant un retinoide solubilise, de type gel hydroglycolique
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
JP6340162B2 (ja) 2012-12-20 2018-06-06 日東電工株式会社 アポトーシス誘導剤
AU2014233420A1 (en) * 2013-03-15 2015-11-12 Laboratory Skin Care, Inc. Fine dry particulate retinoid active agent compositions and topical formulations including the same
JP6602034B2 (ja) 2014-04-02 2019-11-06 日東電工株式会社 標的化分子およびその使用
KR102256453B1 (ko) 2014-04-07 2021-05-25 닛토덴코 가부시키가이샤 소수성 약물 전달용 신규한 폴리머계 하이드로트로프
KR101950693B1 (ko) * 2014-07-24 2019-02-21 주식회사 엘지생활건강 레티놀 또는 레티놀 유도체를 함유하는 마이크로니들
CN106146734B (zh) * 2015-03-31 2018-07-20 中国石油化工股份有限公司 一种偶联剂及其应用以及丁苯无规共聚物及其制备方法
WO2017029665A1 (en) 2015-08-20 2017-02-23 Sol-Gel Technologies Ltd. Compositions for topical application comprising benzoyl peroxide and adapalene
WO2017180440A1 (en) 2016-04-11 2017-10-19 Amcol International Corporation Delivery system based on a natural microparticle for use in personal care and other topical applications
WO2017184868A1 (en) 2016-04-20 2017-10-26 Duke University Compositions, systems and methods for encapsulation and delivery of a substance
WO2019068288A1 (de) 2017-10-04 2019-04-11 Berlimed International Research Gmbh Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung
CN113164368B (zh) * 2018-12-04 2023-06-13 株式会社Lg生活健康 高含量和缓释型类维生素a胶囊以及包含其的皱纹改善用组合物
WO2022192672A1 (en) * 2021-03-11 2022-09-15 Peace Out Inc. Anhydrous skin care composition comprising retinol and/or bakuchiol
EP4322914A1 (de) * 2021-04-16 2024-02-21 DSM IP Assets B.V. Retinolformulierung (ii)
EP4322910A1 (de) * 2021-04-16 2024-02-21 DSM IP Assets B.V. Retinolformulierung (i)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US4826828A (en) * 1985-04-22 1989-05-02 Avon Products, Inc. Composition and method for reducing wrinkles
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US5089269A (en) * 1987-11-07 1992-02-18 Shiseido Company Ltd. Cosmetic containing fine soft microcapsules
ZA892859B (en) * 1988-04-22 1989-12-27 Advanced Polymer Systems Inc Porous particles in preparations involving immiscible phases
ES2060791T3 (es) * 1988-11-16 1994-12-01 Advanced Polymer Systems Inc Composiciones cationicas para aplicacion topica.
US5156843A (en) * 1989-03-20 1992-10-20 Advanced Polymer Systems, Inc. Fabric impregnated with functional substances for controlled release
US5073365A (en) * 1989-06-01 1991-12-17 Advanced Polymer Systems Clinical and personal care articles enhanced by lubricants and adjuvants
JP2980978B2 (ja) * 1989-10-03 1999-11-22 アドバンスド ポリマー システムズ,インコーポレイティド 浸蝕性マクロ多孔性ヒドロゲル粒子及びその調製法
AU639063B2 (en) * 1990-01-29 1993-07-15 Johnson & Johnson Consumer Products, Inc. Skin care compositions
FR2666015B1 (fr) * 1990-08-23 1994-11-10 Oreal Composition cosmetique et/ou dermopharmaceutique contenant de l'acide retinouique ou ses derives, destinee au traitement des cheveux ou du cuir chevelu.
KR100250700B1 (ko) * 1991-06-27 2000-07-01 차알스 제이. 메츠 안정화된 레티노이드 함유 피부 보호용 조성물
ES2221921T3 (es) * 1992-07-13 2005-01-16 Shiseido Company, Ltd. Composicion para preparacion dermatologica.
GR1002207B (en) * 1992-08-06 1996-03-27 Johnson & Johnson Consumer Skin care compositions containing imidazoles.

Also Published As

Publication number Publication date
US5851538A (en) 1998-12-22
ES2168414T3 (es) 2002-06-16
DE69617181T2 (de) 2002-06-06
CA2184433C (en) 2000-01-18
KR100262117B1 (ko) 2000-07-15
AU5831096A (en) 1997-07-03
AU697584B2 (en) 1998-10-08
DK0781551T3 (da) 2002-05-21
PT781551E (pt) 2002-04-29
EP0781551B1 (de) 2001-11-21
JPH09183722A (ja) 1997-07-15
CA2184433A1 (en) 1997-06-30
DE69617181D1 (de) 2002-01-03
JP2960022B2 (ja) 1999-10-06
EP0781551A1 (de) 1997-07-02
KR970032851A (ko) 1997-07-22

Similar Documents

Publication Publication Date Title
ATE209032T1 (de) Retinoid-formulierungen in porösen mikrokugeln für verringerte irritation und verbesserte stabilität
DE59610480D1 (de) Hautpflegemittel für gealterte haut
IL125921A0 (en) Topical compositions comprising an oil-in-water emulsion and a retinoid
DK0578077T3 (da) Præparater, der indeholder retinsyrer og tocopherol
DE69605610T2 (de) Stabile Zusammensetzung, die Ascorbinsäure enthällt
WO1996007396A3 (en) Retinoid compositions
ES2190175T3 (es) Formulacion de gel hidrofobico con base de acetato de vitamina e de aplicacion topica.
ES2176795T3 (es) Composiciones a base de esfingomielanasa y su utilizacion.
DK0812198T3 (da) Stabilisering af prostaglandinpræparater
ES2155874T3 (es) Composiciones cosmeticas que contienen acido betulinico.
BR9712491A (pt) Composições cosméticas
PT784481E (pt) Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humano
PT824152E (pt) Producao microbiana de vitamina b12 e producao e utilizacao de composicoes contendo elevadas concentracoes de actividade de vitamina b12
FR2719768B1 (fr) Utilisation d'extraits de bactéries filamenteuses comme agents cosmétiques contre le vieillissement cutané.
ATE126430T1 (de) Herstellung und verwendung stabiler kleinpartikulärer liposomenzubereitungen.
ES2181763T3 (es) Formulaciones a base de fenbendazol.
DE69719589T2 (de) Retinoide enthaltende Hautpflegepräparate
IT1252061B (it) Composizioni per uso dermatologico e cosmetico
ATE251906T1 (de) Verwendung von vitamine e acetat
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
ES2158187T3 (es) Agente de avivaje.
AU3506095A (en) Clear, thickened topical skin care composition with water-insoluble perfume
ES2121463T3 (es) Uso de procisteina como agente blanqueante de la piel.
NO902104D0 (no) Kosmetisk blanding.
BR9704964A (pt) Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification